Vishal Goyal
Geneve, GE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Model-Informed Drug Development of a Sustained Release Formulation of Flucytosine in the Treatment of Cryptococcal Meningitis: A Case Study Using Physiologically Based Pharmacokinetic Modeling.
Journal: CPT: pharmacometrics & systems pharmacology
Published: November 10, 2024
Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitis.
Journal: Clinical and translational science
Published: March 27, 2024
Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteers.
Journal: Clinical and translational science
Published: November 28, 2023
AmBisome Monotherapy and Combination AmBisome-Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 01, 2021
Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: December 04, 2020
Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India.
Journal: PLoS neglected tropical diseases
Published: November 26, 2019
Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India.
Journal: PLoS neglected tropical diseases
Published: January 28, 2019
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives.
Journal: Clinical microbiology reviews
Published: August 31, 2018
Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India.
Journal: PLoS neglected tropical diseases
Published: April 02, 2018
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh.
Journal: PLoS neglected tropical diseases
Published: June 23, 2016
Phase I (first-in-man) prophylactic vaccine's clinical trials: Selecting a clinical trial site.
Journal: Perspectives in clinical research
Published: April 17, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026